CB vs. NVO
CB (Chubb Limited) and NVO (Novo Nordisk A/S) are both stocks. CB operates in Insurance - Property & Casualty (Financial Services), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, CB returned 11.89%/yr vs 6.20%/yr for NVO. At a 0.17 correlation, their price movements are largely independent.
Performance
CB vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CB achieves a 3.43% return, which is significantly higher than NVO's -16.56% return. Over the past 10 years, CB has outperformed NVO with an annualized return of 11.89%, while NVO has yielded a comparatively lower 6.20% annualized return.
CB
- 1D
- -1.35%
- 1M
- 0.70%
- YTD
- 3.43%
- 6M
- 8.96%
- 1Y
- 10.97%
- 3Y*
- 20.64%
- 5Y*
- 15.72%
- 10Y*
- 11.89%
NVO
- 1D
- -4.52%
- 1M
- -10.96%
- YTD
- -16.56%
- 6M
- -9.23%
- 1Y
- -42.47%
- 3Y*
- -17.53%
- 5Y*
- 1.78%
- 10Y*
- 6.20%
CB vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CB Chubb Limited | 3.43% | 14.46% | 23.89% | 4.20% | 15.97% | 27.85% | 1.41% | 22.94% | -9.63% | 12.82% |
NVO Novo Nordisk A/S | -16.56% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between CB and NVO is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Mar 25, 1993 | 0.17 |
The correlation between CB and NVO shifts across timeframes, from -0.06 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.
Fundamentals
CB:
$127.01B
NVO:
$182.49B
CB:
$28.35
NVO:
$27.42
CB:
11.35
NVO:
1.50
CB:
0.79
NVO:
0.06
CB:
2.67
NVO:
0.56
CB:
1.59
NVO:
0.90
CB:
$48.15B
NVO:
$327.80B
CB:
$17.01B
NVO:
$268.30B
CB:
$12.22B
NVO:
$181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CB vs. NVO — Risk / Return Rank
CB
NVO
CB vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Chubb Limited (CB) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CB | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.44 | ||
| Sortino ratioReturn per unit of downside risk | +2.03 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 0.86 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 1.18 | -0.77 | +1.95 |
| Martin ratioReturn relative to average drawdown | 2.70 | -1.14 | +3.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CB | NVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.62 | -0.82 | +1.44 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.78 | 0.05 | +0.73 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.50 | 0.19 | +0.31 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.40 | 0.47 | -0.07 |
Drawdowns
CB vs. NVO - Drawdown Comparison
The maximum CB drawdown since its inception was -50.99%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for CB and NVO.
Loading charts...
Drawdown Indicators
| CB | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -50.99% | -74.70% | +23.71% |
Max Drawdown (1Y)Largest decline over 1 year | -9.36% | -55.03% | +45.67% |
Max Drawdown (3Y)Largest decline over 3 years | -14.35% | -74.70% | +60.35% |
Max Drawdown (5Y)Largest decline over 5 years | -19.26% | -74.70% | +55.44% |
Max Drawdown (10Y)Largest decline over 10 years | -42.59% | -74.70% | +32.11% |
Current DrawdownCurrent decline from peak | -5.81% | -70.19% | +64.38% |
Average DrawdownAverage peak-to-trough decline | -10.68% | -17.77% | +7.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.52% | 37.21% | -32.69% |
Volatility
CB vs. NVO - Volatility Comparison
The current volatility for Chubb Limited (CB) is 6.11%, while Novo Nordisk A/S (NVO) has a volatility of 9.75%. This indicates that CB experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CB | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.11% | 9.75% | -3.64% |
Volatility (6M)Calculated over the trailing 6-month period | 13.14% | 38.30% | -25.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.69% | 52.08% | -34.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.34% | 38.31% | -17.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.69% | 32.56% | -8.87% |
Dividends
CB vs. NVO - Dividend Comparison
CB's dividend yield for the trailing twelve months is around 1.21%, less than NVO's 4.39% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CB Chubb Limited | 1.21% | 1.22% | 1.30% | 1.51% | 1.49% | 1.65% | 2.01% | 1.91% | 2.24% | 1.93% | 2.07% | 4.23% |
NVO Novo Nordisk A/S | 4.39% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
CB vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Chubb Limited and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CB and NVO have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (9.75%) compared to CB (6.11%). In terms of maximum drawdown, CB dropped -50.99% vs NVO's -74.70%.
CB currently has the higher Sharpe Ratio (0.62 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CB and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer